In addition, the use of direct (CypD independent) mPTP inhibitors [113,114] could also shed a light on the role of the mPTP in Aβ-mediated mitochondrial dysfunction and NLRP3 inflammasome activation in cerebral ECs during CAA and AD pathology. Here, NLRP3 is linked to Alzheimer disease.